Devices and Wearables Library
Every article, presentation, spotlight, and news item we've tagged to Devices and Wearables.
Showing 1–24 of 55
Wearable Pattern Recognition Detects Physiological Drift Before Disease
Oura Ring 5 represents a shift in wearable health technology from passive data collection to predictive pattern recognition, with a smaller form factor designed to increase sustained daily use. The device's Health Radar feature identifies gradual physiological changes across sleep and waking hours—signals that often precede clinical manifestation of cardiovascular and metabolic conditions.
WHOOP’s $575m raise backs always-on health
WHOOP has secured $575 million in Series G funding at a $10.1 billion valuation, positioning itself as a continuous health monitoring platform that translates physiological data into actionable guidance. The funding reflects investor confidence that longevity platforms embedding real-time health tracking into daily life can shift healthcare from reactive to proactive intervention.
Home Blood Sampling Unlocks Protein Analysis at Scale
Alamar Biosciences has developed a dried blood spot extraction kit enabling high-sensitivity protein analysis from fingerstick samples collected at home, potentially accelerating large-scale longevity research by reducing barriers to frequent, consistent biosampling across diverse populations.
Continuous Breathing and Blood Pressure Monitoring in Wearable Form
Oura Ring 5 introduces hardware miniaturization with 40% size reduction and redesigned sensors alongside expanded software for continuous monitoring of breath, circulation, metabolic markers, and recovery. The device architecture addresses signal accuracy across diverse populations while integrating clinical data with daily biometric tracking.
WHOOP enters $34.5m ARPA-H-backed bid to quantify aging
WHOOP has joined a $34.5 million Stanford-led research initiative to develop the first FDA-grade Intrinsic Capacity score, a predictive model designed to quantify functional healthspan and forecast major health outcomes up to 20 years in advance. The THRIVE coalition integrates continuous wearable physiological data with clinical biomarkers and functional assessments to measure resilience and detect early shifts toward vulnerability before disease manifests.
Continuous Blood Pressure Monitoring Without Cuffs
Sky Labs received UK regulatory approval for CART PLATFORM, a cuffless ring-based blood pressure monitor that integrates wearable hardware, mobile app, and cloud analytics. The authorization enables prescription distribution through UK pharmacies and hospitals, establishing clinical-grade continuous blood pressure monitoring as an accessible diagnostic tool.
Beacon Biosignals is turning sleep into brain diagnostics
Beacon Biosignals has developed a home-based EEG headband that records brain electrical activity during sleep, enabling continuous longitudinal monitoring of neural patterns. This approach shifts brain health assessment from single-point diagnostic snapshots to scalable, repeatable data collection that can detect pathological changes years before symptom onset.
Oura launches AI model for women’s health insights
Oura has developed a proprietary AI model specifically designed to contextualize women's health questions using personal biometric data from its wearable ring. The system integrates clinical evidence with continuous physiological signals to provide personalized guidance rather than generic web-based information, addressing a gap in how most AI tools handle women's hormonal and reproductive physiology.
Sky Labs launches ring-type wearable blood pressure monitor for hospitals
Sky Labs has developed CART, a ring-worn wearable that enables continuous, non-invasive blood pressure monitoring in hospital settings without traditional cuffs. This technology extends real-time hemodynamic tracking from intensive care units to general wards, improving early detection of cardiovascular changes and reducing clinical workload.
WHOOP moves into clinical care as Fitbit rebrands to Google Health
Wearable platforms are transitioning from passive data collection to clinical integration, with WHOOP launching telehealth services that connect continuous biometric monitoring to medical records and clinical interpretation. This shift addresses a fundamental gap in current health monitoring: the ability to contextualize patterns within a broader clinical picture and detect meaningful health changes before they become acute problems.
Continuous Blood Pressure Monitoring Reveals Hidden Cardiovascular Patterns
Hilo Core, an FDA-cleared wearable system, generates 30-35 daily blood pressure readings via optical sensing and periodic cuff calibration, shifting cardiovascular monitoring from episodic clinical snapshots to continuous behavioral tracking. This approach addresses a fundamental gap in preventive medicine: most vascular risk accumulates undetected between infrequent clinical measurements.
Continuous Blood Pressure Monitoring Shifts Cardiovascular Risk Assessment
Sky Labs' CART BP pro ring meets clinical standards for cuffless blood pressure monitoring and achieved regulatory clearance across major markets. The device demonstrates that wearable continuous monitoring can achieve accuracy equivalent to traditional methods, expanding clinical adoption pathways for non-invasive cardiovascular surveillance.
Continuous Blood Pressure Monitoring Replaces Cuff-Based Snapshots
Sky Labs' CART ring has received UK medical device authorization, representing a shift from intermittent cuff-based blood pressure monitoring to continuous, wearable cardiovascular tracking. Regulatory approval of cuffless rings signals that healthcare systems now recognize continuous biometric data collection as clinically legitimate, with implications for early detection and long-term cardiovascular risk management.
Smart earbuds bring EEG sleep modulation to consumers
NextSense has commercialized in-ear EEG earbuds that move beyond sleep tracking to real-time neural modulation, using closed-loop audio stimulation timed to reinforce slow-wave sleep. This represents a shift from passive measurement to active intervention in a domain central to longevity—though validation across heterogeneous populations and safety protocols remain open questions.
Wearables may spot brain changes earlier
Continuous passive monitoring via consumer wearables can detect meaningful variability in cognitive and mood patterns over months, capturing environmental and physiological influences on brain function earlier than episodic clinical assessment. The strongest predictive signals—sleep quality, heart rate patterns, and environmental exposure—suggest brain health is fundamentally linked to systemic and environmental conditions rather than isolated neural function.
EEG AI models standardize sleep biomarkers across devices
Beacon Biosignals demonstrated AI-driven sleep staging and arousal detection algorithms alongside clinical validation data for its Waveband device in hypersomnia disorders. The platform's capacity to extract standardized digital biomarkers from multi-device EEG data positions it as a tool for both clinical assessment and pharmaceutical trial endpoints.
Clair Health launches wearable hormone intelligence
Clair Health has launched a non-invasive wearable that uses multimodal biosensors and AI to infer continuous hormonal patterns across the female lifespan, moving beyond episodic blood tests and calendar-based tracking. The device collects skin temperature, heart rate variability, sleep, and breathing data as proxies for endocrine state, positioning hormonal monitoring as a prevention tool rather than a fertility marker.
At-home EEG sleep detection matches clinical-grade accuracy
Beacon Biosignals demonstrated machine learning-based detection of sleep arousals using a 510(k) FDA-cleared at-home EEG headband, with performance metrics comparable to expert clinical assessment. This capability addresses a critical measurement gap in sleep phenotyping for both clinical trials and population health assessment, particularly in populations taking antidepressants where sleep disruption is both common and therapeutically relevant.
Circadian Light Therapy Restores Sleep and Cognition in Mild Impairment
A randomized controlled trial found that home-based light therapy tailored to individual circadian timing improved sleep quality, mood, and cognitive performance in people with mild cognitive impairment. Light exposure calibrated to circadian phase represents a practical intervention accessible outside clinical settings.
Sky Labs secures exclusive CART BP pro distribution with Otsuka in Japan
Sky Labs secured exclusive distribution rights with Otsuka Pharmaceutical to bring CART BP pro, a cuffless blood pressure monitor using photoplethysmography technology, to Japanese hospitals and clinics. The device enables continuous 24-hour blood pressure monitoring without traditional cuffs, addressing a market of 43 million hypertensive Japanese patients where many remain uncontrolled or undiagnosed.
Function acquires Getlabs to scale at-home testing
Function's acquisition of Getlabs removes logistical friction from routine health testing by bringing blood draws directly to patients' homes and offices. This operational change addresses a fundamental barrier to consistent health monitoring—the primary prerequisite for sustained, data-driven health optimization.
Home EEG tracking enables frequent Alzheimer's measurement
A year-long home-based study of 119 participants demonstrates that individuals with mild Alzheimer's disease can reliably self-administer frequent brain health assessments using a wireless EEG headset and cognitive task platform, achieving 99.7% completion rates and generating high-frequency data that may accelerate clinical trial design and reduce costs.
Home EEG Sleep Monitoring Achieves Clinical-Grade Accuracy
Integration of at-home EEG sleep monitoring into decentralized clinical trials enables objective measurement of sleep architecture with 88-96% agreement to laboratory polysomnography. This addresses a critical measurement gap in CNS studies where sleep quality directly influences neurological outcomes and therapeutic response.
Seveno backs PointFit wearable patch
Seveno Capital's investment in PointFit reflects a market shift toward direct biochemical monitoring via wearable patches that measure lactate and other sweat biomarkers in real time. Continuous metabolic substrate tracking—rather than behavioral proxies like step count—provides actionable insight into energy dynamics, recovery debt, and metabolic flexibility relevant to both performance optimization and early detection of metabolic decline.